Thank you, Mark. Good morning, everyone. Thank you all for joining us today. The ESAB team has been busy. More importantly, we have been impactful and have made meaningful progress towards accomplishing our strategic goals. I'm very proud of our team's effort and focus. Our EBX business system continues to drive innovation, margin expansion and higher cash flow. I've actually been out visiting several of our sites and recently had a chance to visit Gothenburg, Sweden and Chennai, India to meet with our engineering teams. I was delighted to see our truly global innovation process at work and the new products we expect to launch in the coming quarters. In Q1, we published our first sustainability report where we highlighted our activities and governance practices. I am pleased with our design efforts to make our products more sustainable and with continued positive community involvement of our associates globally. I'm looking forward to sharing more about our ESG initiatives during our Investor Day. Moving to Slide 3 to talk specifically about the first quarter. We had another quarter of strong performance that exceeded expectations. Organic sales in the first quarter rose 7%, driven by robust demand in our APAC, Middle East and Europe regions and solid performance from the Americas. Adjusted EBITDA was up 12% and margins expanded 80 basis points to 17.4% as our EBX initiatives push margins up and improved working capital. We are pleased with the performance of our new acquisitions. The teams continued to make great strides in integrating and finding synergies for growth and margin expansion. In a few weeks, I'll visit our newest acquisitions, Therapy and Swift-Cut for their 100-day EBX review. At this meeting, we do a deep dive into the business to review progress on synergies and resolve any roadblocks. We're off to a good start this year, and I'm pleased that the positive momentum in our end markets has continued into the second quarter. As a result, we have raised our full year guidance. Kevin will share more on this later. Turning to Slide 4. We've been on a journey to reshape ESAB into a less cyclical, faster-growing, better margin enterprise. And this slide shows our progress towards a higher mix of equipment sales that accelerates achieving this objective. Let me share how we have advanced this strategy. First, through open innovation. We have developed a complete line of light industrial equipment like Rogue, Rebel, Renegade and have begun to introduce our new heavy-duty line of products like the Warrior Edge, Fabricator and RobustFeed. And as you know, we've always protected our R&D spend. Second, acquisitions into robotic torches, automated welding and cutting and our digital solutions portfolio, which we call InduSuite. And last, we've strengthened our gas equipment portfolio with the 2018 acquisition of GCE. Victor products and GCE established leadership gas equine [ph] positions for ESAB in North America and Europe. In the last 12 months, we've expanded this business into more profitable end markets with the additions of Ohio and Therapy equipment. We're confident that this strategy is shifting ESAB into a higher profit mix allowing us to sustainably expand our EBITDA margins to greater than 20%. Moving to Slide 5. Our industry is facing a welder shortage, increased safety requirements and the need to reduce total cost of ownership. At ESAB, we have a robust EBS stage gate process for product development that includes significant time spent gathering the voice of our customers to understand their unmet needs. To solve these broader industry issues, ESAB designed our cobot solution with three important characteristics, one, open architecture, two, digital workflow solution that we call InduSuite and three, the ease of use where one can be trained on our cobot in a matter of hours. I'm encouraged by the funnel our teams have generated. This is just the start, and I look forward to sharing more in the coming quarters. Turning to Slide 6. We continue to drive EBX and lean initiatives throughout our facilities, our continuous improvement initiatives, free up manufacturing floor space, which helps with future rooftop reductions and solve any issues we face within our business. In this specific example, we solved the past due problem and freed up manufacturing space to grow and help consolidate rooftops within ESAB. Through 5S, value stream mapping, we were able to merge production sales to free up 2,500 square feet of manufacturing space and reduced past dues at this facility by 64%. Really pleased with our manufacturing teams and their engagement with lean principles. In fact, we now have a lean competition underway, which is recognizing hard work of our teams and delivering results to the business. Turning to Slide 7 and our financials. First quarter sales grew 7% organically. Our markets continue to perform as expected and remain resilient. APAC, Middle East and Europe continue to show strength, while the Americas have performed in line with expectations. Acquisitions added another 300 basis points of growth. Strong price coupled with cost savings helped offset inflation and currency headwinds in the quarter. EBITDA expanded 80 basis points year-over-year to 17.4%. Moving to Slide 8. Americas had a solid quarter and continues to perform in line with our expectations. Sales rose 5% organically as the team executes on price and acquisitions added 500 basis points of growth. We've accelerated our product line rationalization initiative to drive margins and operational efficiency. As a result, adjusted EBITDA increased 12% and margins expanded 80 basis points to 17%. Turning to Slide 9. Another strong quarter for our EMEA and APAC segments. First quarter sales increased 9% organically, reflecting 5 points of price and 4 points of volume. Acquisitions added 200 basis points of growth, and we continue to experience strong demand in two regions, APAC and the Middle East, with both regions continuing to benefit from strong investment in infrastructure, renewable energy and oil and gas. As mentioned before, the European market continues to be resilient. Adjusted EBITDA improved by 13% and margins expanded 80 basis points year-over-year to 17.8%, reflecting strong execution by the team. With that, let me turn it over to Kevin for Slide 10.